or
forgot password

    • cancer clinical trials in kingston, PA

    • Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Carcinoma, Non-Small-Cell Lung
    MEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Carcinoma, Non-Small-Cell Lung
    Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Osteoporosis
    Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal Women
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Endometrial Hyperplasia, Osteoporosis
    Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
    Medical Oncology Associates of Wyoming Valley, PC
    Kingston, Pennsylvania 18704
    Carcinoma, Non-Small Cell Lung
    Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Breast Neoplasms
    Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer
    Medical Oncology Associates
    Kingston, Pennsylvania 18704
    Colorectal Cancer Metastatic
    Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Carcinoma, Non-Small-Cell Lung
    Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
    Medical Oncology Associates of Wyoming Valley, PC
    Kingston, Pennsylvania 18704
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])
    Medical Oncology Associates of Wyoming Valley, PC
    Kingston, Pennsylvania 18704
    Prostate Cancer
    Study Of AG-013736 In Patients With Refractory Metastatic Renal Cell Cancer
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Kidney Neoplasms, Carcinoma, Renal Cell
    Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
    Medical Oncology Associates of Wyoming Valley, PC
    Kingston, Pennsylvania 18704
    Carcinoma, Non-Small-Cell Lung, Lung Cancer, Neoplasms, Lung, Neoplasms, Pulmonary
    Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer
    Medical Oncology Associates
    Kingston, Pennsylvania 18704
    Metastatic Breast Cancer
    Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC)
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Prostatic Neoplasms
    Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.
    Medical Oncology Associates
    Kingston, Pennsylvania 18704
    Small Cell Lung Cancer
    Trial Of Erlotinib With Or Without PF-3512676 In Advanced Non Small Cell Lung Cancer
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Carcinoma, Non-Small-Cell Lung
    Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal Tumors
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Gastrointestinal Stromal Tumor
    Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Non-Small Cell Lung Cancer
    A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Breast Neoplasms
    Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy
    Medical Oncology Associates
    Kingston, Pennsylvania 18704
    Small Cell Lung Cancer
    Expanded Access Program for Maraviroc At Multiple Centers
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Advanced HIV Infection
    A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Breast Neoplasms
    A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Neoplasms
    A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Carcinoma, Non-Small Cell Lung
    Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Colorectal Neoplasms
    Study Of SU011248 In Combination With Paclitaxel/Carboplatin In Patients With Advanced Solid Tumors
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Neoplasms
    AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy
    Medical Oncology Associates
    Kingston, Pennsylvania 18704
    Small Cell Lung Cancer
    A Study Of PF-03732010 In Patients With Advanced Solid Tumors
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Neoplasms
    A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Advanced Solid Tumors
    Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Ewing's Sarcoma Family of Tumors
    Safety And Pharmacology Of SNX-5422 Mesylate In Subjects With Refractory Hematological Malignancies
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Hematologic Neoplasms
    Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Carcinoma, Squamous Cell, Carcinoma, Adenosquamous, Carcinoma, Large Cell, Carcinoma, Non-Small-Cell Lung
    Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Colorectal Neoplasms
    A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
    Medical Onc Assoc of Wyoming Valley, PC- US Oncology
    Kingston, Pennsylvania 18704
    Pancreatic Neoplasms
    Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Carcinoma, Large Cell, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Adenosquamous Cell
    A Study On An Immunostimulant Antibody In Combination With Chemotherapy For Advanced Cancer Of The Pancreas
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Pancreatic Neoplasm
    Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Advanced Cancer, Advanced Solid Tumors
    Follow-Up Study for Exubera
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Diabetes Mellitus
    Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast Cancer
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Advanced Breast Cancer
    Rollover Protocol for Prior SU011248 Protocols
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Solid Tumors
    Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Menopause, Osteoporosis
    Study Evaluating Inotuzumab Ozogamicin (CMC-544) Plus Rituximab In Diffuse Large B-Cell Non-Hodgkin's Lymphoma
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Lymphoma, B-Cell
    A Safety And Pharmacokinetic Study With CVX-045 In Patients With Advanced Solid Tumors
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Advanced Solid Tumors, Neoplasms, Carcinoma, Cancer, Malignancy
    Safety And PK Study Of CVX-060 In Patients With Advanced Solid Tumors
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Advanced Solid Tumors, Neoplasms, Carcinoma, Cancer, Malignancy
    A Safety Study Of A Monoclonal Antibody Against A5B1 Integrin In Solid Tumors
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Advanced Non-Hematologic Malignancies
    A Safety, Tolerability, And Pharmacokinetic Trial With CVX-241 In Patients With Advanced Solid Tumors
    Pfizer Investigational Site
    Kingston, Pennsylvania 18704-5535
    Advanced Solid Tumors, Epithelial Ovarian Cancer (EOC) or Primary Peritoneal Cancer (PPC)